Werbung
Werbung

CALC

CALC logo

CalciMedica, Inc. Common Stock

5.83
USD
Gesponsert
+0.50
+9.47%
09. Jan., 15:59 UTC -5
Geschlossen
exchange

Nach-Markt

5.84

+0.01
+0.17%

CALC Ergebnisberichte

Positives Überraschungsverhältnis

CALC übertreffen die 7 der letzten 20Schätzungen.

35%

Nächster Bericht

Datum des nächsten Berichts
25. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.33
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-36.54%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-13.16%

CalciMedica, Inc. Common Stock earnings per share and revenue

On 12. Nov. 2025, CALC reported earnings of -0.52 USD per share (EPS) for Q3 25, missing the estimate of -0.42 USD, resulting in a -23.57% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +4.05% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 6 analysts forecast an EPS of -0.33 USD, with revenue projected to reach -- USD, implying an decrease of -36.54% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, CalciMedica, Inc. Common Stock reported EPS of -$0.52, missing estimates by -23.57%, and revenue of $0.00, 0% as expectations.
The stock price moved up 4.05%, changed from $3.21 before the earnings release to $3.34 the day after.
The next earning report is scheduled for 25. März 2026.
Based on 6 analysts, CalciMedica, Inc. Common Stock is expected to report EPS of -$0.33 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung